Kynos is a clinical stage biopharmaceutical company focusing on the development of novel treatments for patients suffering from acute and chronic inflammatory diseases. It is owned by Dr. Falk Pharma GmbH and therefore a part of the Falk Group.
https://drfalkpharma.com/en/
Company Details
- Employees
- 3
- Founded
- 2020
- Address
- 1-3 Charter Square, Sheffield,s1 4hs,united Kingdom
- Industry
- Biotechnology
- Website
- http://www.kynostx.com
- Keywords
- Biotechnology, Drug development, Inflammation, Immunometabolism, Acute Kidney Injury, Acute Pancreatitis, KMO.
- HQ
- Sheffield
Kynos Therapeutics Questions
Kynos Therapeutics's website is http://www.kynostx.com
Kynos Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/kynos-therapeutics-ltd
Kynos Therapeutics has
3 employees.
View email and phone details for 3
employees at Kynos Therapeutics.
Kynos Therapeutics's industry is
Biotechnology
Kynos Therapeutics's top competitors are
Invizius,
Aten Therapeutics Ltd,
Dr. Falk Pharma,
Trogenix,
Seroba.,
Resolution Therapeutics,
Nrg Therapeutics,
Macomics,
Epidarex Capital,
Caldan Therapeutics.
Kynos Therapeutics's categories are Biotechnology
Kynos Therapeutics's founding year is 2020
